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Key Findings  
 
 Obesity, overweight and 
diabetes have increased in 
Finland during the last few 
decades. 
 It appears that the increase 
in the prevalence of adult 
obesity has come to a halt in 
the last few years.  
 There is no fully reliable in-
formation on changes in the 
incidence of type 2 diabetes, 
but judging by the reim-
bursements granted for med-
icine expenses and the popu-
lation’s glycated hemoglobin 
levels, the increasing trend 
appears to have stopped in 
the last 10 years. 
 WHO aims to stop obesity 
and diabetes from becoming 
more prevalent on a global 
scale.  
 Finland should aim to reduce 
the prevalence of over-
weight, obesity and diabetes. 
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INTRODUCTION 
The World Health Organization (WHO) has published its action plan for the prevention 
and control of noncommunicable diseases for 2013−2020. The action plan includes pro-
posals for health policy and practical action. The objective is for the member states to 
reach as many as possible of the nine international targets pertaining to the prevention 
and treatment of noncommunicable diseases by the year 2025. The attainment of the 
said targets is being monitored through 25 indicators, which represent risk of premature 
mortality, levels of noncommunicable disease risk and protective factors as well as the 
potential for and realisation of prevention and treatment. The baseline of the monitoring 
is year 2010. 
The WHO action plan is primarily focused on four important disease groups: cardiovascu-
lar diseases, cancer, diabetes and chronic respiratory diseases. Disease prevention fo-
cuses on lifestyle factors: smoking, unhealthy diet, lack of physical activity, and harmful 
use of alcohol. 
An evaluation has been conducted in Finland on the current state and previous devel-
opment of noncommunicable diseases and their risk factors to estimate how realistic the 
targets set by WHO are for Finland. At the same time, national challenges have been 
identified along with possibilities for improving the prevention of noncommunicable 
diseases. 
 
This “Data Brief” publication reports WHO’s obesity and diabetes target (target 7) and its 
indicators. 
DEVELOPMENT OF ADULT OBESITY IN FINLAND 
According to the FINRISK 2012 Health Survey, the mean BMI is 26.9 kg/m
2
 for working-
age men and 25.9 kg/m
2
 for  working-age women (Table 1). Two out of three men (65%) 
and almost half of the women (46%) are overweight. Every fifth Finn is obese. Approxi-
mately 30% of men and women have abdominal obesity. The trend toward obesity 
among Finns seems to have come to a halt in the last five years. 
 
Table 1. Overweight and obesity in 25−64-year-old men and women in 2007−2012. 
 
 FINRISK 2007 FINRISK 2012 p-value 
MEN    
 BMI, kg/m
2
 26.8 26.9 0.47 
    ≥25, % 64.0 64.5 0.82 
    ≥30, % 18.6 20.3 0.19 
 Waist, cm 95.8 95.5 0.24 
    >100 cm, % 31.8 30.7 0.61 
WOMEN    
 BMI, kg/m
2
 26.2 25.9 0.06 
    ≥25, % 49.2 46.3 0.03 
    ≥30, % 19.2 20.0 0.55 
 Waist, cm 86.2 85.0 <0.05 
    >90 cm, % 32.0 31.0 0.32 
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CHILD AND ADOLESCENT OBESITY 
The percentage of overweight children and adolescents has more than doubled in Finland 
since the late 1970s. According to the Child Health Monitoring Survey (LATE), more than 
10% of children under school age were overweight or obese. Amongst 5th and 8th class 
pupils in the Finnish school system, 25% of boys and 20% of girls were overweight or 
obese (Figure 1). 
 
Figure 1. The percentage of overweight children in LATE-study 2008. 
 
 
THE  PREVALENCE OF DIABETES AND BLOOD SUGAR LEVELS 
The prevalence  of diabetes can be analysed on the basis of comprehensive general popu-
lation survey data and register data. The prevalence of diabetes should be objectively 
analysed in general population surveys by measuring fasting blood sugar levels or by 
conducting an OGTT. However, conducting measurements in large general population 
surveys is extremely challenging and expensive. According to current knowledge, the 
glycated haemoglobin level (HbA1c) can also be used to analyse the incidence of diabe-
tes.  
 
Amongst Finns without diagnosed diabetes, the average glycated hemoglobin has re-
mained on the same level from 2002 to 2012. The average HbA1c for both men and 
women was 5.3% in 2012. In the same time, the HbA1c levels of diabetics reduced from 
7.3% to 6.7% for men and from 7.2% to 6.3% for women. Based on the HbA1c levels, an 
indirect conclusion can be made: the prevalence of diabetes had not increased and the 
level of care offered to diabetics had improved during 2002−2012. 
 
Figure 2. Change in HbA1c 2002−2012 in the FINRISK survey. Men and women aged 25–
74, age-standardised mean values. 
  
 
The number of Finns over 35 entitled to special reimbursement for medicines due to 
diabetes has doubled in the last 20 years (Figure 3).  In 2014, 6.3% of men and 5.1% of 
women were entitled to special reimbursements for medicines for diabetes. Among the 
+35 age group, the respective percentages were 10.4% of men and 8.0% of women.  
WHO targets for 2010–2025 
 
1. A 25% relative reduction in 
risk of premature mortality 
from cardiovascular dis-
eases, cancer, diabetes and 
chronic respiratory diseas-
es. 
2. At least 10% relative re-
duction in the harmful use 
of alcohol, as appropriate, 
within the national con-
text. 
3. A 10% relative reduction in 
prevalence of insufficient 
physical activity. 
4. A 30% relative reduction in 
mean population intake of 
salt/sodium. 
5. A 30% relative reduction in 
prevalence of current to-
bacco use in persons aged 
15+ years. 
6. A 25% relative reduction in 
the prevalence of raised 
blood pressure. 
7. Halt the rise in diabetes 
and obesity. 
8. At least 50% of eligible 
people receive drug thera-
py and counselling to pre-
vent heart attacks and 
strokes 
9. An 80% availability of the 
affordable basic technolo-
gies and essential medi-
cines required to treat ma-
jor noncommunicable dis-
eases.  
 
 
WHO indicators for obesity and 
diabetes 
 
Age-standardized prevalence of 
raised blood glucose/diabetes 
among persons aged 18+ years 
(defined as fasting plasma glucose 
concentration ≥ 7.0 mmol/l (126 
mg/dl) or on medication for raised 
blood glucose) 
 
Prevalence of overweight and 
obesity in adolescents  
 
Age-standardized prevalence of 
overweight and obesity in 
persons aged 18+ years (defined as 
body mass index ≥ 25 kg/m² for 
overweight and body mass index ≥ 
30 kg/m² for obesity) 
 
The indicators cannot be created 
from the Finnish information 
sources exactly in the same form. 
No diabetes No diabetes Diabetes Diabetes 
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The materials used 
 
The FINRISK survey materials from 
2002 to 2012 were used for the 
purpose of this analysis. Weight, 
height and waistline have been 
measured using standardised 
methods. HbA1c levels have been 
analysed in a THL-accredited 
laboratory. 
 
The data pertaining to child and 
adolescent obesity have been 
collected from the LATE study. 
 
The special reimbursement infor-
mation is based on the statistics of 
the Social Insurance Institution of 
Finland. 
http://www.kela.fi/kelasto 
 
Figure 3. The prevalence of special reimbursements for diabetes medicines 
granted by the Social Insurance Institution of Finland from 1994 to 2014 
amongst men and women aged 35 and plus. 
 
 
There was a particular rise in the total number of new reimbursement rights 
made between 2006 and 2011. The number of decisions applicable to the 35+ 
age sector increased at the time from approximately 12,500 in 2006 to almost 
32,000 in 2011.  The increase in decisions has been influenced by the start of 
drug treatment directly from diagnosis, in accordance with the Current Care 
Guideline issued in 2007 and the related change in the right to special reim-
bursement, as well as the unusually active screening for diabetes realised at the 
end of the previous decade. After this, the number of decisions to grant special 
reimbursement has dropped to below 25,000/year.  
 
Figure 4. The incidence of new special reimbursements for diabetes medicines 
per 100 persons granted by the Social Insurance Institution of Finland from 
1994 to 2014, amongst men and women of 35 and plus. 
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DISCUSSION 
Even though the health of Finns has improved and life expectancy has significantly in-
creased since the 1970s, obesity and diabetes have also become more commonplace.  In 
addition to type 2 diabetes, obesity is a risk factor for many chronic diseases, such as cardi-
ovascular diseases, many forms of cancer, asthma, depression and diseases of the muscu-
loskeletal system.  
 
The majority of the adult population is currently overweight or obese. In the last ten years, 
the increase in obesity has halted. Abdominal obesity has even slightly decreased. The 
increase of obesity in children and adolescents is worrying.   
 
In fighting obesity, prevention is key because the treatment of existing obesity is difficult, 
results are scarce, and they are often only temporary. Preventive measures should specifi-
cally target children and adolescents, because overweight children often turn into obese 
adults. A healthy diet and meal frequency, portion sizes proportional to the amount of 
energy spent, motivation to exercise, and creating an environment promoting exercise are 
the cornerstones of obesity prevention. 
 
The monitoring of the obesity trend in children and adolescents and early interventions 
should be emphasised. Child health clinics and school health care are already conducting 
the necessary measurements, but systematic and comprehensive data collection is not 
possible due to the use of several varying data systems. Children's growth curves and 
overweight/obesity screening rules have recently been revised in Finland. However, adding 
them to the electronic patient records has been slow. Tackling child obesity is still regarded 
as challenging. Clinical pathways for childhood obesity have not been created for all areas, 
and there is a delay in directing obese children to receive treatment.    
 
As obesity is becoming more commonplace, type 2 diabetes has also become a national 
disease. Judging by HbA1c levels, however, the average blood sugar level of the population 
has not risen during the last decade. This observation is in line with the halt in the increase 
of overweight and obesity. 
 
The number of diabetics receiving drug treatment is still increasing. The prevalence of drug 
treatment and the quantity of special reimbursements are affected both by the number of 
diabetics in the population, the comprehensiveness of screening and diagnostics, treat-
ment recommendations, and indications for special reimbursements. The improved prog-
nosis for diabetes also increases the number of diabetics receiving drug treatment; more 
and more people live longer with diabetes. At the start of the millennium, the national 
Development Programme for the Prevention and Care of Diabetes (DEHKO) invested in the 
screening and early detection of diabetes. This may in part explain the great increase in 
identified diabetics at the beginning of the millennium. 
 
Because the special reimbursement-based estimates on the prevalence of diabetes and on 
the changes in the prevalence are affected by treatment practices, caution should be taken 
in the interpretation of the results. Furthermore, the register data only includes persons 
already diagnosed with the disease. Diabetes may, however, remain symptomless for a 
long time. Therefore, a large number of people on the population level meet the criteria of 
diabetes even though they have not been diagnosed with it.  This is why the data based on 
the special reimbursements underestimates the scale of the problem. At the moment, our 
health monitoring system cannot create up-to-date data on the number of diabetics, taking 
into account the diabetics who are yet to be identified. 
 
As is the case with many chronic diseases, socioeconomic differences are also clear in the 
prevalence of overweight and diabetes. Both are most common among men and women 
having less education. The differences start to develop at an early stage and can already be 
detected at school age. 
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